InvestorsHub Logo
icon url

tke458

02/15/23 4:05 PM

#403065 RE: Number sleven #403064

Even if that’s true, he still had a much higher cost basis and (IMHO) will do what he needs to do to get the SP much higher than where it’s at today and with a much greater sense of urgency than this team has exhibited
icon url

Whalatane

02/15/23 4:37 PM

#403073 RE: Number sleven #403064

N7. So Sarissa says

Sarissa is Amarin’s largest shareholder, owning more than 25 million shares. We are long term shareholders and have not sold any shares since acquiring our position.



Kiwi
icon url

dukesking

02/15/23 4:49 PM

#403084 RE: Number sleven #403064

Here’s where the evidence doesn’t support LTRO’s made up theory and incorrect assumption. I don’t know if Denner sold or not, I haven’t checked yet. I did check the share price of AMRN stock during the 4th quarter. If Denner sold in 4th quarter, he didn’t drive the price down.
9-1-22 $1.17
10-3-22 $1.12
10-13-22 $1.21
10-24-22 $1.11
11-3-22 $1.17
11-17-22 $1.16
12-1-22 $1.19
12-19-22 $1.19
12-30-22 $1.21
icon url

oneragman

02/15/23 5:53 PM

#403125 RE: Number sleven #403064

Ns, absolutely not true. Denner has a significant activist position. Any 1% change needs to be reported in a couple of days. So you would have seen the entire ride down then back up being reported. That didn't happen! Why do you think Morgan Stanley has 22M shares? If it was Denner, he would have had to report the increases at an accelerated pace which would tip off management. This way management wasn't aware of the position until we were already in the voting period. This was all planned going back months right down to the day the battle would commence. Denner hasn't sold a share period, but was having allies accumulate. From a strategic perspective, he nailed it!
icon url

ggwpq

02/16/23 10:33 AM

#403216 RE: Number sleven #403064

Ns, I respect your view. Can you name one drug that's doing greater than $1B/year in EU, as promised by AMRN management, not marketed by a BP? TIA.